North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Columbia University · with National Institute of Neurological Disorders and Stroke (NINDS) · NCT01694940
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 16
- Study start
- January 31, 2011
- Record last updated
- February 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Conditions: Mitochondrial Disorders; Mitochondrial Genetic Disorders; Mitochondrial Diseases; Disorder of Mitochondrial Respiratory Chain Complexes; Deletion and Duplication of Mitochondrial DNA
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patients diagnosed with or suspected to have a mitochondrial disorder
- Adult carriers of known mitochondrial DNA mutations
- Patients with laboratory analysis indicative of a mitochondrial disorder.
- Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria.
Exclusion Criteria
- Patients not suspected of having a mitochondrial disorder
- Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.
Recruiting US locations
University of California San Diego
San Diego, CA 92103
Site contact: Richard Hass, MD · 18588226700 · rhass@ucsd.edu
Lucile Packard Children's Hospital
Stanford, CA 94305
Site contact: Gregory Enns, MD · 1-650-723-6858
Children's Hospital of Colorado
Aurora, CO 80045
Site contact: Johan Van Hove, MD PhD MBA · 3037242351
Children's National Medical Center
Washington D.C., DC 20010
Site contact: Andrea Gropman, MD · 202-476-3511 · agropman@cnmc.org
University of Florida
Gainsville, FL 32610
Site contact: Peter Stacpole, MD · 13522658909 · stacpool@gcrc.ufl.edu
Massachusetts General Hospital
Boston, MA 02115
Site contact: Amel Karaa, MD · 6173556117 · akaraa@partners.org
Mayo Clinic
Rochester, MN 55902
Site contact: Ralitza Garivolova, MD · 15072842511 · gavrilova.ralitza@mayo.edu
Columbia University Medical Center
New York, NY 10032
Site contact: Michio Hirano, MD · 2123051048 · namdc@columbia.edu
Virtual Site (Remote enrollment)
New York, NY 10032
Site contact: Kristin T Engelstad · 2123056834 · namdc@columbia.edu
Akron Children's Hospital
Akron, OH 44308
Site contact: Bruce Cohen, MD · 13305436048 · bcohen@chmca.org
Cleveland Clinic
Cleveland, OH 44195
Site contact: Sumit Parikh, MD · 12164441994 · parikhs@ccf.org
Case Western Reserve University
Clevland, OH 44106
Site contact: Charles Hoppel, MD · 12163683147 · charles.hoppel@case.edu
The Children's Hospital of Philadelphia
Philadelphia, PA 19104
Site contact: Marni J Falk, MD · 2155904564 · falkm@email.chop.edu
Children's Hospital of Pittsburgh
Pittsburgh, PA 15224
Site contact: Amy Goldstein, MD · 1-412-692-5520
Baylor College of Medicine
Houston, TX 77030
Site contact: William Craigen, MD · 17137988305 · wcraigen@bcm.edu
Seattle Children's Hospital and Regional Medical Center
Seattle, WA 98105
Site contact: Russell Saneto, MD · 12069872100 · russ.saneto@seattlechildrens.org
Study contacts (from the official record)
- Michio Hirano, MD · 12123051048 · NAMDC@columbia.edu
- Kristin Engelstad, MS · 12123056834 · NAMDC@columbia.edu
Similar studies in California
All diabetes studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
TIXiMED, Inc.
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Regeneron Pharmaceuticals
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Glendale, CA + 3 other US sites
- Eligibility basics
- Ages 18–75